DMC Recommends Biophytis Continue Sarconeos COVID-19 Study
Frequency Therapeutics Stock Craters After FX-322's Four Weekly Regime Shows No Benefit In Sensorineural Hearing Loss
AnaptysBio's Imsidolimab Fails To Separate From Placebo In Skin Blistering Disorder Study
Chimerix's DSTAT Shows Promising Results In First Cohort Of COVID-19 Study
Phase 2 Recent News
Revance Therapeutics' DaxibotulinumtoxinA For Injection Improves Muscle Tone In Mid-Stage Upper Limb Spasticity
Nektar Therapeutics Secures $150M From SFJ Pharma For New Study With BEMPEG/Pembrolizumab Combo In Head & Neck Cancer
Clene To Start Testing CNM-ZnAg In COVID-19 Patients In Brazil
Windtree Therapeutics' AEROSURF Drug Delivery Device Secures US Patent
Exelixis' Cabozantinib Data Shows Clinically Significant Benefit Versus Pfizer's Sutent, In A Type Of Kidney Cancer
Cortexyme Stops Enrollment In Mid-Stage Atuzaginstat Study In Alzheimer's Disease
Heat Biologics Cell Therapy Shows Survival Benefit In Mid-Stage Lung Cancer Study, Shares Rally
Innate Pharma To Test Lacutamab In Relapsed/Refractory Peripheral T-Cell Lymphoma Patients
Otonomy Rips 90% After Meniere's Disease Drug Achieves Primary Endpoint
Ironwood's Pipeline Needs Work, Analyst Downgrades
Getting Into The Drug Business: From NDAs To PDUFA Dates
Synthetic Biologics Crashes Following Disappointing Phase 2 Results
Novo Nordisk Announces Positive Phase 2 Trial Results, Shares Spike Higher